Corporate Tech Investors

RCT BioVentures

RCT BioVentures is a corporate VC investing group that invests in firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

The RCT BioVentures program is the vehicle through which Research Corporation Technologies invests in start-up or early-stage companies whose technologies promise patented biomedical products with a clear competitive advantage. RCT has assets of more than $300 million to advance technology development through flexible, long-term investment options. Our initial financial commitment to our portfolio companies usually ranges from several hundred thousand dollars to several million dollars, and we reserve additional funds for the subsequent funding of successful companies.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/15/2021

Transaction History

Our records indicate that RCT BioVentures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chairman

John McIntyre

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

RCT BioVentures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

RBC Technology Ventures | RealNetworks

Share this article

About Our Corporate Tech Investor Database

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary